This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Genecraft, Inc., Lg Electronics Inc.. Active years: 2002-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2024
Title: Woo-jin Kim: Innovator in Gene Therapy
Introduction
Woo-jin Kim is a prominent inventor based in Seoul, South Korea, known for his significant contributions to the field of gene therapy. With a total of three patents to his name, Woo-jin's work focuses on enhancing the efficiency and safety of gene expression using innovative nucleic acid molecules.
Latest Patents
Among his latest patents is a notable invention described as a "Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene." This patent presents a nucleic acid molecule that includes an asymmetrically modified inverted terminal repeat (ITR). This innovation is part of an AAV vector that boasts increased productivity and expression efficiency of a transgene while simultaneously reducing genotoxicity, courtesy of the unique asymmetric ITR modification.
Another significant patent by Woo-jin Kim is the "Modified complex platform of adeno-associated virus with improved rate of expression of loaded genes and reduced genotoxicity." This patent reveals an adeno-associated virus (AAV) complex platform that also incorporates an asymmetrically modified ITR. The AAV complex offers the same advantages—enhanced productivity and expression efficiency of transgenes, alongside decreased genotoxicity.
Career Highlights
Woo-jin Kim has worked with reputable companies such as Genecraft, Inc. and LG Electronics Inc. His career reflects a strong commitment to advancing genetic research and technology through innovative solutions.
Collaborations
Throughout his career, Woo-jin has collaborated with notable individuals in the field of genetics, including Suk Chul Bae and You Soub Lee. These partnerships have further enriched his research endeavors and contributed to his success as an inventor.
Conclusion
In summary, Woo-jin Kim stands out as an influential inventor in the realm of gene therapy, holding patents that significantly enhance the efficiency and safety of gene expression. His work continues to pave the way for advancements in genetic research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile